Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Assembly Biosciences (ASMB) Other Operating Expenses (2016 - 2021)

Historic Other Operating Expenses for Assembly Biosciences (ASMB) over the last 6 years, with Q4 2021 value amounting to $41.6 million.

  • Assembly Biosciences' Other Operating Expenses changed N/A to $41.6 million in Q4 2021 from the same period last year, while for Sep 2022 it was $41.6 million, marking a year-over-year change of. This contributed to the annual value of $41.6 million for FY2021, which is N/A changed from last year.
  • Per Assembly Biosciences' latest filing, its Other Operating Expenses stood at $41.6 million for Q4 2021.
  • Over the past 5 years, Assembly Biosciences' Other Operating Expenses peaked at $41.6 million during Q4 2021, and registered a low of -$127000.0 during Q2 2018.
  • For the 4-year period, Assembly Biosciences' Other Operating Expenses averaged around $4.1 million, with its median value being $4.5 (2017).
  • Its Other Operating Expenses has fluctuated over the past 5 years, first tumbled by 3971352.66% in 2018, then soared by 10434.78% in 2019.
  • Quarter analysis of 4 years shows Assembly Biosciences' Other Operating Expenses stood at -$447.0 in 2017, then plummeted by 18244.52% to -$82000.0 in 2018, then skyrocketed by 104.88% to $4000.0 in 2019, then soared by 1040850.0% to $41.6 million in 2021.
  • Its Other Operating Expenses stands at $41.6 million for Q4 2021, versus $4000.0 for Q2 2019 and $1000.0 for Q1 2019.